Search results
Equities Analysts Issue Forecasts for Pfizer Inc.’s Q3 2025 Earnings (NYSE:PFE)
ETF DAILY NEWS· 2 days agoZacks Research analyst K. Shah now forecasts that the biopharmaceutical company will post earnings per share of $0.72 for the quarter, down from their previous estimate of ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days ago(Suzhou) Co., Ltd. celebrated its grand opening in Suzhou Industrial Park (BioBAY). This marks a significant milestone that will further enhance the high-quality development of Suzhou's < ...
Ardelyx (NASDAQ:ARDX) Given “Overweight” Rating at Piper Sandler
ETF DAILY NEWS· 2 days agoPiper Sandler reiterated their overweight rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research note released on Friday morning, Benzinga reports. The brokerage currently has ...
Biocon and Handok link to commercialise Liraglutide in South Korea
Pharmaceutical Technology via Yahoo Finance· 3 days agoIndian biopharmaceutical company Biocon has entered an exclusive licence and supply agreement with...
ABVC CEO's Letter to Shareholders: The Future Looks Bright for ABVC; Anticipating Cash Incomes...
NewMediaWire via Yahoo Finance· 5 days agoFREMONT, CA - (NewMediaWire) - May 22, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a...
MediciNova receives US patent allowance for eye cancer treatment By Investing.com
Investing.com· 7 days agoMediciNova, Inc., a biopharmaceutical company listed on NASDAQ:MNOV and Tokyo Stock Exchange (Code...
Xenetic Biosciences names James Parslow as interim CEO By Investing.com
Investing.com· 4 days agoXenetic Biosciences, Inc. (NASDAQ:XBIO), a biopharmaceutical company specializing in immune-oncology...
BioLineRx reports positive pancreatic cancer trial results By Investing.com
Investing.com· 3 days agoBioLineRx Ltd. (NASDAQ: BLRX), a biopharmaceutical company, announced encouraging results from the...
Jump Financial LLC Has $317,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)
ETF DAILY NEWS· 1 day agoThe institutional investor owned 11,300 shares of the biopharmaceutical company’s stock after selling 191,700 shares during the period. Jump Financial LLC’s holdings in Royalty ...
Soleno Therapeutics Inc (SLNO) Stock: A Closer Look at the Market Potential – News Heater
NewsHeater· 39 minutes agoCompany’s 36-month beta value is -1.40.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.” The public float for SLNO is 21.26M, and currently, short sellers hold a 14